What Is Psyence Biomedical Ltd. (PBM) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Psyence Biomedical Ltd.'s intrinsic value is estimated at $3.09, presenting a divided outlook at the current price of $2.85. With an average implied return of +8.6% across a split 4–4 (bull–bear) consensus, the model spread of +342.4% underscores analytical uncertainty. Notably, EPV sees the most upside at +262.5% (fair value: $10.33), while Bayesian DCF is the most conservative at -79.9% ($0.57). The spread between these extremes — +342.4% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About PBM?
9 of 13 models are currently active for PBM. Of these, 5 models suggest upside while 4 models suggest overvaluation. The Bayesian DCF estimates PBM's intrinsic value at $0.57, implying -79.9% downside from the current price. See which stocks rank higher →
How Does PBM Rank in Pharmaceutical Preparations?
Among 440 Pharmaceutical Preparations stocks, PBM ranks #415 by Quality of Company score. CirclFi's QOC score of 2.2/10 evaluates 32 fundamental signals. A score of 2.2 signals below-average fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
Within the Pharmaceutical Preparations space, Psyence Biomedical Ltd. competes in an environment where clinical trial success rate often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.
Is PBM a Value Trap?
The Value Trap algorithm is not active for PBM. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
9 of 13 models are active for Psyence Biomedical Ltd.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Psyence Biomedical Ltd.'s fundamental quality profile registers 2.2/10. This concerning score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +342.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every PBM valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across PBM's 9 active models, average confidence is 17%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad